Merck & Co., Inc., Kenilworth, N.J., USA Publishes 2015/2016 Corporate Responsibility Report
Merck & Co., Inc., Kenilworth, N.J., USA recently issued its 2015/2016 Global Corporate Responsibility Report. The report provides an overview of the company’s corporate responsibility activities, progress and performance in the areas of Access to Health, Environmental Sustainability, Employees and Ethics & Transparency.
Highlights from the 2015/2016 report include:
- Advancing the company’s pipeline in areas of significant unmet medical need, including cancer, the hepatitis C virus and life-threatening infections;
- Recognizing retired scientist William C. Campbell, Ph.D., for receiving the 2015 Nobel Prize in Medicine or Physiology for his discovery leading to a treatment for river blindness;
- Protecting the lives of mothers and children through MSD for Mothers, including work with partners to reduce maternal mortality rates by nearly half in target districts of Uganda and Zambia, and decreasing stock-outs of contraceptives in Senegal from more than 80 percent to less than 2 percent nationwide;
- Launching products and initiatives to protect the health and well-being of companion animals, food production animals and equine through the company’s Animal Health business while supporting the education of the next generation of veterinarians who will lead the animal health industry in the future;
- Attaining all three of the company’s environmental goals ahead of schedule, including a 29 percent reduction in water use since 2009, and a 22 percent reduction in greenhouse gas emissions since 2012;
- Significantly increasing business with diverse suppliers and small enterprises, and instituting a more formal program to evaluate the risks for labor and human rights impacts in the supply chain;
- Initiating a volunteerism campaign in recognition of the company’s 125th anniversary, challenging employees to report 125,000 volunteer hours to support their local communities;
- Launching a comprehensive strategic plan to attract and retain talent while building an inclusive workplace where every employee can thrive and where the company can leverage its diversity for greater innovations in cutting edge science.
The company continues to use several external guidelines and measurement frameworks to inform the scope of its reporting, including the Global Reporting Initiative Guidelines (GRI G4), the Sustainable Development Goals, the Access to Medicine Index and the United Nations Global Compact.